-
Mashup Score: 17FDA Clears Prime Medicine’s IND for First Prime Editing Therapy - 13 hour(s) ago
Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational new drug (IND) application for the company’s first candidate to enter the clinic.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 17
Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational new drug (IND) application for the company’s first candidate to enter the clinic.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 17
Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational new drug (IND) application for the company’s first candidate to enter the clinic.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 8At Chardan Conference, David Liu Foresees First Prime Editing Clinical Trial in 2024 - 7 month(s) ago
Genome editing pioneer David R. Liu, PhD, tells investors prime editing is on track to join base editing in human clinical trials in less than a year.
Source: www.genengnews.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0ASGCT News: David Liu Hails Rapid Progress in Precision Genome Editing - 12 month(s) ago
In an exemplary keynote address by David Liu, the developer of base and prime editing salutes the rapid uptake of “CRISPR 2.0” editing technologies around the world, as indicated by a succession of encouraging preclinical studies.
Categories: Future of Medicine, Latest HeadlinesTweet-
In an exemplary keynote address by @davidrliu, the developer of base and #primeediting salutes the rapid uptake of “#CRISPR 2.0” editing technologies around the world, as indicated by a succession of encouraging preclinical studies. Learn more: https://t.co/31gxSUnOG7 #ASGCT23 https://t.co/P1TA2eZOvf
-
-
Mashup Score: 1ASGCT News: David Liu Hails Rapid Progress in Precision Genome Editing - 12 month(s) ago
In an exemplary keynote address by David Liu, the developer of base and prime editing salutes the rapid uptake of “CRISPR 2.0” editing technologies around the world, as indicated by a succession of encouraging preclinical studies.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1CRISPR-Based Prime Editing Generates Mouse Models of Cancer Mutations - 12 month(s) ago
Scientists make mice with the prime editing system engineered into their genome available for labs to carry out their own studies of cancer mutations.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 6CRISPR-Based Prime Editing Generates Mouse Models of Cancer Mutations - 12 month(s) ago
Scientists make mice with the prime editing system engineered into their genome available for labs to carry out their own studies of cancer mutations.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Dual AAVs Enable In Vivo Prime Editing - 1 year(s) ago
A new Nature Biotechnology article from the lab of prime editor pioneer David Liu shows high-efficiency prime editing in vivo in mice.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Dual AAVs Enable In Vivo Prime Editing - 1 year(s) ago
A new Nature Biotechnology article from the lab of prime editor pioneer David Liu shows high-efficiency prime editing in vivo in mice.
Categories: Future of Medicine, Latest HeadlinesTweet
.@PrimeMedicine said it has gained FDA clearance for the first human trials of a #primeediting therapy as the agency has approved an investigational new drug (IND) application for the company’s first candidate to enter the clinic. Read more: https://t.co/b7inw1Eavf https://t.co/hgoPINUf5M